Monday, December 31, 2012




As I wake up this morning on the last day of 2012, I feel very humble and do not take each day for granted any more. As the New Year approaches we all have a new beginning. Why don’t we in 2013 treat ourselves to KNOWLEDGE? That is the best gift of all! For with education we can add power to our own bodies. Just think if we all gain KNOWLEDGE on ways to take care of our health, then we will be a more productive world.

This new year I would like to challenge you to go on the internet or read a book at least one hour a day and gain trust back into your mind with the education of healing ourselves with what GOD has given us. There is so much out there all you have to do is seek it.

2013 will be a better year if we all take part and educate one another. There is a saying that comes to my mind that we are all drops in the ocean, but together we create an ocean. Lets be that ocean in making peace, love and good will.

May each of my followers have a healthy and peaceful New Year and continue to grow with the resources of the new technology we have available to us.

Go now with the POWER OF KNOWLEDGE.

Sunday, December 30, 2012







FDA secretly legalizes GM salmon during holidays while nobody was watching

Saturday, December 29, 2012 by: J. D. Heyes

Learn more:

(NaturalNews) Once the bastion of purity, seafood has now entered the realm of "manufactured" sustenance, thanks to a couple of U.S. government bureaucracies.

The Food and Drug Administration has granted permission to a firm that will allow it to produce GM salmon, a decision that has been called a genetically modified food "breakthrough" by breathless journalists who obviously don't understand the gravity of what has just occurred.

According to Britain's Independent newspaper, the FDA's decision means the salmon - which reportedly grow twice as fast as ordinary fish - "could become the first genetically-modified animal in the world to be declared officially safe to eat."

In reaching its decision FDA officials said they couldn't find any valid scientific reasons to ban production of GM Atlantic salmon, which are engineered using extra genes from two other species of fish - the Pacific Chinook salmon and an eel-like species called the ocean pout.

A 'perfect storm' of deceit regarding GM foods

The agency's decision clears the last legal hurdle that stood in the way of GM fish production; reports said the FDA's decision is liable to put renewed pressure on producers of salmon in Britain and throughout Europe to follow its lead.

As in the past, government scientists - inside the U.S., the United Kingdom and elsewhere - have bought off on the notion of genetically modified foods as a way of increasing the world's food supply in general; consumers, however, have always taken a much more cautious approach (as they should).

Misguided supporters of GM fish think the newly created salmon will make it easier and cheaper to produce on salmon farms, but they are also buying into the notion that manufacturing GM fish will be better for the environment because they can also be grown on land-based farms.

A couple years ago Sir John Beddington, Britain's current chief scientist, warned there would be a "perfect storm" of a swelling global population combined with climate change and food shortages, making it "very hard to see how it would be remotely sensible to justify not using new technologies such as GM."

Those "warnings" have become typical of GM proponents - scare tactics aimed at forcing acceptance of a "science" that enriches the companies managing it at the expense of the people they are allegedly trying to serve.

Opponents of GM fish have it right: They argue that introducing such fast-growing salmon creates unacceptable risks to human health and the environment; they also know that permitting genetically modified fish to be produced will likely lead to more GM animal production, which could eventually destroy entire food chains.

Before issuing its decision, the FDA had already said the salmon was fit for human consumption, but in a draft environmental assessment published recently but written in May, the agency went a step further, "declaring that the production of the GM fish is unlikely to have any detrimental impact on the wider environment," the paper said.

Opponents disagree. Dubbing the GM salmon "Frankenfish," they warn that the modified species could at some point escape into the wild then interbreed with wild fish, thereby undermining the genetics of certain species, especially the endangered Atlantic salmon, known as the "king of fishes" grown on fish farms in the UK.

It's a biotech food world

AquaBounty Technologies of Maynard, Mass., which has developed the AquAdvantage salmon, has downplayed any such threat, saying they will be only be grown as sterile females and kept in secure, land-based containers.

The FDA concurred the risk is negligible, saying such an occurrence would be "extremely remote" at best.

"[The] FDA has made the preliminary determination it is reasonable to believe that approval of the AquAdvantage salmon NADA [New Animal Drug Application] will not have any significant impacts on the quality of the human environment of the United States (including populations of endangered Atlantic salmon) when produced and grown under the conditions of use for the proposed action," said the FDA assessment.

It sounds like it is just a matter of time before we can add GM fish to the growing list of modified foods that already exist around the world.

Learn more:

Thursday, December 27, 2012






Hello, well another year is ending and one is starting as we enter 2013. I would like to wish all of you a healthy and peaceful year ahead.

This year my older sister Linda and I got together to create a delicious organic Christmas Dinner. I would like to thank Marcie Mendez for providing the food we were able to have for our meal. THANKS TO CO-OPS.

The main dish was the turkey, organic and plump with juices that were out of the world. My nephew carved it just right with a perfect setting at their home . The trimmings of a giant salad with everything but the kitchen sink, mash potatoes, sweet potatoes, fresh spinach, cranberry sauce, stuffing, and red wine. The best news of all it was all organic!!!

I even made organic, gluten free deserts. My taste buds enjoyed the chocolate cake and chocolate chip walnut cookies.

It is possible to be healthy and with research and knowledge able to keep it cost efficient. There are food co-ops that are in your area, it just takes a little research and you would be surprised how cheap it can be. You will notice the different taste between foods that are tainted with poisons via organic foods. GO GREEN.

Here are some pictures from my wonderful Christmas dinner.

My all of you gain the knowledge of keeping healthy and fear no more of the uncertainly of our foods and chemicals that we are using. IT’S THE POWER THAT YOU WILL GAIN THAT WILL KEEP YOU HEALTHY.


Wealth, what is it? Many of us are wealthy
in numerous ways although we simply do not
recognize it. Enjoy the wealth you already
have in your family and friends, in your
health, in your freedom, in your knowledge,
and most importantly, in yourself. 




Tuesday, December 25, 2012



some LOVE Energy into
someone that needs a boost.
They won't forget it...
in fact, they will pass it on
to another! •*¨*•.¸¸¸¸.•*¨*••*¨*
May this day bring you Peace and Love.
Sherry Malin

Monday, December 24, 2012



Christmas  Eve

It’s the time

of the year again.

I would like to thank

all of you that have prayed

and helped me through this

Journey of cancer. This is the

time that I can rejoice for I have

managed my cancer and I am humble.

There is hope out there, its just all about

education. Knowledge is Power and it just takes

a little bit of time to look on the internet to see all

the other options that surrounds us. May this year bring you

peace and love with

Good health

Ƹ̵̡Ӝ̵̨Ʒ♥ •.¸¸.•´¯`•.♥♫•♥.•´¯`•.¸¸.•


Sunday, December 16, 2012





It’s the holidays again and a celebration of joy and peace. I have a lot to celebrate for this marks two years that I was diagnosed with breast cancer. If you have been following my journey, you can see that through the years I have been honest and spelled my life across the internet. The purpose was to educate and let you know that there are options out there for treatments that do not have side effects. I not only shared Dan’s and my experience, but also expressed other forms of treatments that work. Along with what we can do to manage cancer and I have shared what we can do to prevent cancer and other illnesses.

As I look back through the posts on the blog, I have been very humble to say that I have managed my cancer and will continue to follow my new lifestyle. It’s all about maintaining and keeping this horrible illness in coming back.

So this year I am giving the gift of knowledge and would like to celebrate the work of my doctor ~ Dr. Perez. The passion that drew me to functional medicine will allow me to share the process of what other countries have to offer in treatments.

May this New Year bring you peace and understanding of the whole picture and not just what is in your little corner.

Merry Christmas and Happy Holiday.

Sheryl Malin

Saturday, December 15, 2012

Diagnosing cancer


Difference Engine: Blissful ignorance

Oct 14th 2011, 15:56 by N.V. | LOS ANGELES 
    MEN in America, Europe and other developed regions of the world have a 16% chance of being diagnosed with prostate cancer at some point during their lives—and yet they have only a 3% chance of dying from the disease. Despite the statistics, an industry has grown up around treating prostate cancer which, in most cases, would be best left well alone. The problem is finding the few instances where the cancer is aggressive enough to spread. Unfortunately, lacking better diagnostics, 48 men have to be needlessly treated—at considerable discomfort and possible change in lifestyle for the worse—so that one man's life may be spared.

    Three out of four men in America aged 50 or older have had a PSA test, often unbeknown to themselves during a routine check-up. The test measures the amount of prostate-specific antigen floating around in the blood. PSA is a protein made in the prostate gland to help sperm do its job. The test, which has nothing directly to do with a man's reproductive capacity, is carried out solely to screen for prostate cancer.

    So, what is wrong with that? For a start, while elevated levels of PSA in the blood can indicate the presence of cancer cells in the prostate, higher levels than normal can also be caused by an enlarged prostate (common in older men), infection, inflammation, irritation, head-ache pills like ibuprofen, and whether the person concerned recently had sex. Even a doctor's digital rectal examination (“thumb up the bum”) can raise a patient's PSA level.

    The widely used PSA test has been criticised for giving too many false-positive results, which, in turn, lead to over-treatment of cancers that might never have caused harm. Among men with PSA levels in the warning zone (between four and ten nanograms of PSA per millilitre of blood), biopsies show that over two-thirds of them had no trace of prostate cancer. Meanwhile, one in six men with PSAs in the normal zone (below 4ng/mL) were subsequently found to have been harbouring cancer cells in their prostate glands.

    Usually a family doctor will refer a patient to a urologist if his PSA level is above 4ng/mL—or if the level rises by more than 0.35ng/mL over the course of a year. Because of the vagaries of the PSA blood test, many urologists confronted with borderline cases have started using a biomarker in the urine that focuses on a gene called PCA3. Comparing the activity level of the PCA3 gene with that of the PSA gene can be twice as accurate as relying on a PSA test alone. Based on such findings, the urologist may recommend a biopsy.

    But that has problems, too. Tissue cores are taken from various parts of the prostate using an instrument with a dozen hollow needles that is inserted via the rectum. The sampling covers only a minuscule part of the prostate, making it easy to miss regions where cancerous cells may lurk. The procedure is not painless and can cause infection, fever, bleeding, problems with urination, and other conditions requiring hospitalisation.
    In the laboratory, a pathologist slices the cylindrical biopsy samples taken from the patient's prostate and examines them under a microscope. A grade is assigned, first, to the most common tumour pattern and, second, to the next most common pattern. The two grades, each with ranges 1 to 5, are added together to give what is called a Gleason score ranging from  2 to 10. For a Gleason score of 7, the combination 4+3 denotes a more aggressive cancer than 3+4.

    With a Gleason score of 6 or less, the urologist may advise active surveillance rather than surgery or radiation. “Watchful waiting” involves tracking the PSA level every three months or so and having an annual biopsy. That may be the best advice the patient will ever receive. But it does require that the person is content to live with the knowledge that he has cancer and has chosen not to have it treated. Most men find that daunting—and opt for treatment, even though medically it may not be warranted.

    Even in cases where a biopsy proves positive, the majority of cancer cells found are likely to be localised and to grow so slowly as never to cause even the symptoms of prostate cancer, let alone death. The condition has been likened to a handful of tortoises crawling around the bottom of a well. In the vast majority of instances, they remain trapped at the bottom. But, once in a while, a tortoise manages to crawl up the side and escape into the surroundings.

    In the majority of cases, men who do nothing about cancer cells found in their prostates will most likely die in old age of something else—heart attack, stroke, lung cancer, pneumonia or whatever—long before they would have succumbed to prostate cancer. In other words, they will die with the disease, not from it. The same goes for the vast majority of men who live in blissful ignorance, having never had a PSA test. Autopsies show that three out of four men who reached the age of 85 had prostate cancer but died of other causes.
    Yet, the urgency to treat any detected cancer—whether aggressive or not—can be immense. The pressure to do so can come as much from the patient himself (“Get that thing out of me!”) as from a medical professional (“To be on the safe side, we advise surgery or radiation.”). Such screening can cause serious stress and anxiety. Researchers at Harvard and Brigham & Women's Hospital in Boston have found that just being diagnosed with prostate cancer doubles the risk of dying from heart attack or suicide.

    If over-detection resulting from PSA screening and biopsies has its risks, over-treatment involves even bigger ones. None of the treatments—and there are half a dozen or so different ones to chose from—is benign.

    Among men who opt to have their prostates removed—often to treat cancers that would never have harmed them—0.5% die within a month due to complications from the surgery. Up to 7% have serious problems but survive. And between 20% and 30% of those treated with surgery or radiation finish up with erectile dysfunction, urinary incontinence and other disabilities. Of those who use chemotherapy to suppress the hormones that feed cancerous cells in the prostate, 40% become impotent.

    If truth be told, the PSA test can cause more grief than relief. There is no evidence that the test provides any advantages, even to men who turn out to have the fast-growing version of the disease. The first sign of the invasive form of prostate cancer occurs too late for it to be treated successfully. No amount of screening will prevent those destined to develop the deadly, untreatable form of the disease from doing so. In the final analysis, PSA screening has allowed more prostate cancers to be detected, but it has not lowered the death rate from the disease.

    Even the scientist who discovered PSA over 40 years ago has argued vociferously for routine testing of prostate-specific antigen levels to be abandoned. Richard Ablin, professor of immunobiology and pathology at the University of Arizona, has called the test based on his work “a public health disaster” that is little better than the toss of a coin. So why is it still used? “Because drug companies continue peddling the tests and advocacy groups [encourage] men to get screened,” Dr Ablin wrote in the New York Times.

    Two years ago, the United States Preventive Services Task Force, an independent panel of medical experts empowered to evaluate cancer testing, recommended against PSA screening for men over 75 years of age. Being older and frailer, such men were viewed as unlikely to benefit from having surgery, radiation and other treatments that were unlikely to prolong their lives, but could well cause incontinence and impotence. At the time, the panel made no change in its recommendation for younger men.

    Having reviewed the findings of leading studies in Europe and America, the Task Force has now downgraded its previous recommendation on prostate-cancer screening for younger men. In an announcement on October 7th, the panel noted that for men 50 to 69 years old the reduction in death caused by prostate cancer ten years after screening “is small to none”. In other words, the PSA test does not save lives, and is not needed by healthy men showing no symptoms of the disease. The risks it causes outweigh any benefits it may bestow.

    But even Dr Ablin admits PSA testing has a place. “After treatment for prostate cancer, for instance, a rapidly rising [PSA] score indicates a return of the disease,” he wrote in his Op-Ed piece last year. And men with a family history of prostate cancer should probably get a regular PSA test. At present, PCA3 screening looks a better bet, but it could turn out eventually to have similar drawbacks as PSA.

    The real problem with prostate-cancer screening—whatever the test employed—is the over-treatment that ensues. If that could be eliminated, even the PSA test might do more good than harm. Ultimately, what is needed, of course, is a way of identifying the odd tortoise that escapes from the well, while ignoring all the other critters that will never do any harm. That is something science has yet to deliver.

    A Different Approach to Cancer


    Smart cancer patients ask tough questions – of themselves and their doctors. They want to know WHY the cancer started growing in their body. They want to know WHY the environment around the cancer cells allowed it to ‘take hold.’ They want to know if there are underlying causes. They want to FIX the Whycauses so their body can cure itself. Alternative treatment does NOT kill cancer; only your body can do that. From an integrative perspective, we want to correct the environment that allowed the disease. “Integrative” doesn’t mean “anti-medical,” it means “to sanely work together for the betterment of the patient.” Chemo and radiation may be the best option! However, if not coupled with correction of the cause, it doesn’t take a rocket scientist to figure out that the cancer has a pretty good chance of re-appearing.  READ MORE:

    From Beehives to Prostate Cancer Treatment

    From Beehives to Prostate Cancer Treatment

    by Rob Mitchum

    A common feature of pharmacies and organic grocery stores is the aisle of natural remedies, featuring bottle upon bottle of herbs, extracts, and oils that promise a wide range of medical benefits. For legal reasons, the health claims made by these products are often fuzzy, boasting of vague antioxidant or anti-inflammatory activity. But online, the compounds are touted as a cure-all for everything from the common cold to depression to cancer, despite often scarce scientific evidence to support such claims. In many cases, scientists aren’t even sure what these compounds do on a biological level, limiting their usefulness in the clinic even if an anti-disease effect could be conclusively demonstrated.
    The major obstacle to determining how a natural remedy works (or doesn’t) is the difficulty in assessing the totality of its effects upon a cell, rather than just the effect on one particular factor at a time. But a technique recently invented by University of Chicago researchers to monitor the activity of hundreds of proteins at once allowed scientists to assess the anti-cancer potential of one natural remedy aisle staple: beehive propolis.

    “A typical problem in bringing some of these herbal remedies into the clinic is that nobody knows how they act, nobody knows the mechanism, and therefore researchers are typically very hesitant to add them to any pharmaceutical treatment strategy,” said Richard Jones, assistant professor in the Ben May Department for Cancer Research and Institute for Genomics and Systems Biology. “Now we’ll actually be able to systematically demonstrate the parts of cell physiology that are affected by these compounds.”

    Beehive propolis is a sticky resin that honeybees use to patch up holes and fill cracks in their hives. Natural remedy suppliers sell this “bee glue” in the form of capsules or liquid extract, touting its abilities to boost immunity, fight off infections, and soften skin. According to anecdotal reports, the substance has been used for centuries to treat sore throats, allergies, and burns, or for less medicinal purposes such as car wax and instrument polish.

    Chih-Pin Chuu, at the time a post-doctoral researcher in Jones’ laboratory, wanted to examine whether the active compound in beehive propolis — called caffeic acid phenethyl ester, or CAPE — was effective against cancer cells. Testing concentrations of CAPE that you would expect to find in the blood after a person swallowed a propolis capsule, Chuu found the compound successfully inhibited the growth of early-stage prostate cancer cell in culture dish experiments. Subsequent experiments on mice implanted with human prostate cancer cells confirmed CAPE’s anti-cancer effect, and hinted at a mechanism.

    “If you feed CAPE to mice daily, their tumors will stop growing. After several weeks, if you stop the treatment, the tumors will begin to grow again at their original pace,” Jones said of the results, published in the journal Cancer Prevention Research. “So it doesn’t kill the cancer, but it basically will indefinitely stop prostate cancer proliferation.”

    That activity suggests CAPE could be a promising co-treatment alongside a chemotherapy drug that targets the cells. But if CAPE were to truly make the crossover from holistic remedy to clinical option, the scientists would also have to demonstrate how the compound freezes cancer cells in a non-proliferative state. Enter the micro-western array, the innovative proteomics technique first described in 2010 by Jones and colleagues.

    Western blots are a common laboratory tool used to measure the changes in protein levels and activity under different conditions. But whereas only one or a few proteins at a time can be monitored with Western blots, micro-western arrays allow researchers to survey hundreds of proteins at once from many samples. Chuu, Jones and their colleagues ran micro-western arrays to assess the impact of CAPE treatment on the proteins of cellular pathways involved in cell growth — experiments that would have been prohibitively expensive without the new technique.
    cape-diagram“What this allowed us to do is screen about a hundred different proteins across a broad spectrum of signaling pathways that are associated with all sorts of different outcomes. You can pick up all the pathways that are affected and get a global landscape view, and that’s never been possible before,” Jones said. “It would have taken hundreds of Westerns, hundreds of technicians, and a very large amount of money for antibodies.”
    With the micro-western array, researchers could quickly build a new model of CAPE’s cellular effects. Treatment with CAPE suppressed the activity of proteins in the p70S6 kinase and Akt pathways, both important sensors of sufficient nutrition that give the green light to cell proliferation when activated. To confirm that this suppression was the key mechanism for CAPE to stop cell proliferation, the team confirmed that over-expressing components of those pathways protected the cancer cells against the compound’s effects.

    “It appears that CAPE basically stops the ability of prostate cancer cells to sense that there’s nutrition available,” Jones said. “They stop all of the molecular signatures that would suggest that nutrition exists, and the cells no longer have that proliferative response to nutrition.”

    Despite the promising results in laboratory and mouse models, much more testing would need to be done before CAPE could legitimately be considered a clinical weapon against prostate cancer. One concern is that there is nobody with deep pockets to pay for the clinical trials needed to prove its effectiveness and safety in humans, since CAPE/propolis is a widely available, over-the-counter compound that can’t be patented by a drug company seeking profit. But Jones hopes that settling the issue of what CAPE (or other natural remedies the lab is currently testing) does to cellular pathways could make clinicians more comfortable in trying them alongside traditional drugs.

    “It’s a rare event that a drug that’s not put forth by a pharmaceutical company goes through a clinical trial, so we’ll see how that works,” Jones said. “But if we were able to work out the mechanisms, you could say, A-ha, this compound would actually be beneficial in combination with other commonly-used therapies.”


    Curcumin is a potent tool in the war against prostate cancer and dementia

    Monday, February 27, 2012 by: John Phillip

    (NaturalNews) Curcumin, the active anti-inflammatory compound found in the Indian spice tumeric, has gained an impressive reputation in the fight against many deadly forms of cancer. New evidence released in the journal Cancer Research finds that the natural phenol can slow prostate tumor growth by blocking receptors used to propagate cell tissue growth.

    Additional research published in the journal PLoS One explains the precise mechanism exerted by curcumin molecules to target the amyloid fibrils associated with the unnatural progression of protein-like plaque tangles that are characteristic in Alzheimer's disease patients. Adding curry spice to your healthy diet or supplementing daily with a standardized curcumin capsule will help win your individual war against cancerous proliferation and Alzheimer's dementia.

    Prostate cancer is one of the most common forms of the disease, with more than 250,000 diagnoses in the US each year. Any natural compound that targets the proliferation of prostate cancer cells would provide a significant remedy compared with the allopathic methods of radiation, surgery and chemical agents. To conduct the study, researchers subjected prostate cancer cells to hormone deprivation in the presence and absence of curcumin with 'physiologically attainable' doses.

    Curcumin blocks prostate cell receptors to thwart cancer progression

    The researchers found that curcumin blocked two genetic receptors necessary for prostate cancer advancement. These receptors have been shown is past studies to predict cancer incidence and rate of growth of existing tumors. They noted that the spice extract was "a potent inhibitor of both cell cycle and survival in prostate cancer cells."

    The lead study author, Dr. Karen Knudsen and her team found that other cancer cell lines multiply by a similar receptor mechanism and may also be inhibited by the curry compound. She commented that curcumin "also has implications beyond prostate cancer... in other malignancies, like breast cancer. In tumors where these play an important function, curcumin may prove to be a promising therapeutic agent."

    In a separate research body, scientists found that curcumin prolongs life and enhances activity of brain neurons, acting as a neuroprotective shield against Alzheimer's disease advancement. The research team determined that curcumin acted to prevent the damaging accumulation of amyloid fibrils around the nerve synapse. Amyloid tangles are known to prevent normal electrical and chemical transmissions required to form memories and maintain cognition.

    Scientific research models continue to extol the virtues of natural spice and herbal extracts such as curcumin to help prevent and treat many deadly diseases that kill countless millions each year. Incorporate curry spices as part of your healthy diet or include a daily supplement (250 mg to 500 mg standardized curcumin extract) to significantly lower cancer risk and support healthy brain function.

    Learn more: